Associations between Ser447Ter gene polymorphism of lipoprotein lipase and atherosclerotic cerebral infarction

Chinese Journal of Medical Genetics

Volumn 23, Issue 5, 2006, Pages 519-522

  Guan, Guo Dong ^a   Xu, En ^a   Wang, Xiao Juan ^a   Xu, Yin Hong ^a   Qiu, Shao Dong ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerotic cerebral infarction; Genetic polymorphism; Lipid metabolism; Lipoprotein lipase

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN LIPASE;

ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN INFARCTION; CONTROLLED STUDY; DNA POLYMORPHISM; HUMAN; LIPID BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; ALLELES; CEREBRAL INFARCTION; CHOLESTEROL, HDL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TRIGLYCERIDES;

EID: 33750286618     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Mead JR, Irvine SA, Ramji DP. Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med, 2002, 80:753-769.
2. Goldberg IJ, Merkel M. Lipoprotein lipase: physiology, biochemistry, and molecular biology. Front Biosci, 2001, 6:D388-405.
3. Zhao SP, Tong QG, Xiao ZJ, et al. The lipoprotein lipase Ser447Ter mutation and risk of stroke in the Chinese. Clin Chim Acta, 2003, 330:161-164.
4. Mamputu JC, Levesque L, Renier G. Proliferative effect of lipoprotein lipase on human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 2000, 20:2212-2219.
5. Chen W, Srinivasan SR, Elkasabany A, et al. Influence of lipoprotein lipase serine 447 stop polymorphism on tracking of triglycerides and HDL cholesterol from childhood to adulthood and familial risk of coronary artery disease: the Bogalusa heart study. Atherosclerosis, 2001, 159:367-373.
6. Hendemon HE, Kastelein JJ, Zwinderman AH, et al. Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins. J Lipid Res, 1999, 40:735-743.
7. Zhang H, Henderson H, Gagne SE, et al. Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochim Biophys Acta, 1996, 1302:159-166.
8. Skoglund-Andersson C, Ehrenborg E, Fisher RM, et al. Influence of common variants in the CETP, LPL, HL and APO E genes on LDL heterogeneity in healthy, middle-aged man. Atherosclerosis, 2003, 167:311-317.
9. David J, Matthew R, Robert A, et al. Lipoprotein lipase (LPL) gene variation and progression of carotid artery plaque. Stroke, 2003, 34:1176-1180.
10. Shimo-Nakamshi Y, Urabe T, Hattori N, et al. Polymorphism of the lipoprotein lipase gene and risk of atherothrombotic cerebral infarction in the Japanese. Stroke, 2001, 32:1481-1486.
11. Sattar N, Petrie JR, Jaap AJ. The atherogenic lipoprotein phenotype and vascular endothelial dysfunction. Atheroscler, 1998, 138:229-235.
12. Clee SM, Loubser O, Collins J, et al. The LPL S447DX Csnp is associated with decreased blood pressure and plasma triglycerides, and reduced risk of coronary artery disease. Clin Genet, 2001, 60:293-300.
13. Sass C, Hwenard H, Gerard S, et al. Lipoprotein lipase(C/G)447 polymorphism and blood pressure in the Stanislas Cohort. J Hypertens, 2000, 18:1775-1781.
14. Baum L, Chen L, Masliah E, et al. Lipoprotein lipase mutations and Alzheimer's disease. Am J Med Genet, 1999, 88:136-139.